The biodistribution of [1- 14 
Determining the biodistribution of drugs in the body after oral or systemic administration is of value both for guiding toxicological studies and for identifying sites of retention of the drugs that can account for pharmacokinetic behavior. Drug levels in tissues for biodistribution studies can be quantified by using either mass spectrometry for drugs that incorporate only stable isotopes or autoradiography and/or scintillation counting for radiolabeled drugs.
In the case of ethanol, pharmacokinetic measurements of plasma ethanol levels in human studies indicate that ethanol has a volume of distribution approximating that of total body water (0.5-0.7 l/kg) and that it rapidly distributes to tissues. In animal studies, biodistribution determinations have mostly been concentrated on the pharmacokinetics of brain uptake of ethanol (Sunahara et al., 1978; Richardson et al., 1987; Smolen and Smolen, 1989; Robinson et al., 2000; Gulyas et al., 2002; Jamal et al., 2003; Quertemont et al., 2003; Peris et al., 2006) . These studies have used both radiolabeled and unlabeled forms of ethanol and have indicated that ethanol rapidly enters the brain after systemic administration and that brain levels equilibrate with blood levels.
Compared with the number of brain studies, relatively few studies have been conducted on the whole-body organ distribution of ethanol or its metabolites. We are aware of only two animal studies that have measured the biodistribution of radiolabeled ethanol across multiple body organs (Ho et al., 1972; Akesson, 1974) . Both of these studies used a film autoradiographic approach and a nonquantitative analysis of radioactivity levels in the images. In the present study a more extensive and quantitative analysis of the whole-animal biodistribution of radioactive ethanol in rats was undertaken using phosphoimaging. Tissue dissection and counting experiments in mice were also conducted to determine the time course and relative proportions of unchanged [1- 14 C] ethanol versus radiolabeled metabolites in various organs. In addition, the effect of an alcohol dehydrogenase inhibitor on the accumulation of radioactivity was evaluated. The goal of the [ 14 C]ethanol experiments in the present study was to identify sites of concentration of ethanol or its metabolites that may contribute to toxicological and pharmacokinetic characteristics of this substance. radioactivity in the tissue. The second portion was used to determine the percentage of radioactivity in the tissue that was nonvolatile. For this, 0.5 ml of unlabeled ethanol was added, and the homogenate was evaporated to dryness overnight under vacuum. Whole-Body Autoradiography in Rats. Rats were lightly anesthetized with isoflurane, and a catheter was secured in a tail vein. They were then allowed to awaken in a restraint device, administered 32 mg (40 Ci; 1.4 MBq) of [1- 14 C] ethanol in saline via the tail vein catheter, and returned to their home cage. After either 15 or 60 min following the [1-
14 C]ethanol administration, the rats were sacrificed by isoflurane overdose and were snap-frozen in a dry ice-hexane slurry. A blood sample was taken immediately by cardiac puncture before the animal was frozen. For autoradiography, the frozen carcasses were sectioned using a whole-body cryosectioning instrument (custommade), and the frozen sections were covered in Mylar film and exposed to phosphor screens at Ϫ30°C to prevent loss of [1- 14 C] ethanol from the section. Exposure to the phosphor screens was continued for 40 h after which the screens were removed and scanned in a PhosphorImager to image radioactivity. To enable quantification of the radioactivity levels in the sections, tissue punches were made in various locations in the sections (liver, rump, and shoulder) using a 12-mm diameter cork borer, followed by weighing and digestion of the tissue punches in Solvable (PerkinElmer Life and Analytical Sciences), addition of scintillation cocktail, and counting in a scintillation counter. To determine the radioactivity accounted for by nonvolatile metabolites, sections from one rat at each sacrifice time point were subjected to a freeze-drying procedure and then reimaged on the phosphor screens.
Data Analysis. For the mouse [1-14 C]ethanol biodistribution study, disintegrations per minute values were converted to percent injected dose per gram. To calculate the percentage of radioactivity that was nonvolatile, the radioactivity after vacuum drying of the homogenates was divided by that in the original homogenates.
For the whole-body autoradiography in rats, mean pixel values for regions of interest drawn over the images were converted to disintegrations per minute values by comparison with the direct scintillation counting of punches taken from the sections and the radioactive blood sample. Radioactive gelatin standards placed on each plate were additionally used to verify the disintegrations per minute values and the linearity of the phosphor screen response. Disintegrations per minute values were then converted to % injected dose per g by assuming an average tissue density of 1 g/ml and dividing by the radioactive dose of 14 C administered to the animal. For the whole-body autoradiograph sections subjected to freeze-drying, quantitation was similar to that in the frozen sections except that disintegrations per minute per gram values in the tissue punches taken from the sections were converted to disintegrations per minute per gram original wet weight by recording the loss of weight in adjacent punches from the drying step. This was done to facilitate direct comparison of radioactivity levels in the dehydrated versus frozen sections.
Results

[1-
14 C]Ethanol Biodistribution in Mice. A study on the time course of [1-14 C]ethanol biodistribution after i.v. administration was conducted in mice ( Fig. 1 ). After administration, radioactivity was present in all organs dissected. After 60 min, radioactivity levels declined from their initial values by 60 to 75%. The decline of tissue radioactivity in the brain and kidney was approximately in proportion to that in the plasma whereas that in the liver was slower. At all time points, the brain contained significantly less radioactivity than that in the other tissues.
To determine the percentage of tissue radioactivity at the different time points that was accounted for by volatile [1-
14 C]ethanol relative to that of nonvolatile [1-
14 C]ethanol metabolites, a sample of the tissue homogenates from each mouse was vacuum dried under alkaline conditions before counting. This procedure indicated that the majority of the radioactivity in the tissues was accounted for by nonvolatile [1- 14 C] metabolites, even at the 5-min time point (Fig. 1 ). Similar percentages of nonvolatile radioactivity (89 -99% nonvolatile at 60 min) were also observed in spleen, muscle, lungs, and intestine (data not shown).
Whole-Body Autoradiography in Rats. To obtain a more detailed image of the radioactivity distribution after [1-
14 C]ethanol administration, a whole-body autoradiography study was conducted in rats Table 1 ). Radioactivity after i.v. [1-
14 C]ethanol administration in the rat showed a widespread distribution among body organs, especially at the early (15-min) time point. The highest levels were apparent in the Harderian glands, salivary and preputial glands, and pancreas. Significant levels were also present in the liver, lungs, stomach wall, and bone marrow. Brain levels of radioactivity were below those in the blood at both the early and late (60-min) time points.
To estimate the relative proportions of radioactivity in the sections accounted for by volatile ethanol versus nonvolatile radiolabeled ethanol metabolites, sections from one animal from each of the 15-and 60-min time points were freeze-dried and reimaged ( Fig. 3 ; Table  2 ). When calculated relative to the original wet weight of the section, the overall radioactivity levels were lower in the dehydrated sections compared with those in the corresponding frozen sections, reflecting a loss of volatile [1- 14 C] ethanol from the section. The greatest difference was apparent at the 15-min time point. At the 60-min time point only a minor level of the radioactivity was represented by volatile [1-
14 C]ethanol in most tissues examined. However, some organ-toorgan differences in the amount of radioactivity accounted for by [1-14 C] ethanol were observed, with greatest levels of volatile radioactivity being observed in the Harderian and especially the preputial glands and the lowest levels in the liver, kidney, and pancreas.
To gain further insight into the relative contributions of [1-
14 C]ethanol versus [ 14 C]ethanol metabolites in accounting for the distribution of radioactivity in various organs, two rats were administered the alcohol dehydrogenase inhibitor, 4-methylpyrazole (30 mg/kg i.p.), 30 min before the [1-
14 C]ethanol administration and sacrificed at 15 or 60 min after 14 C administration (Fig. 4) . After imaging of the sections, they were freeze-dried and reimaged as described previously. Compared with the untreated rats, in the 4-methypyrazole-treated rats, the percent injected dose per gram values for 14 C (Table 3) were significantly higher in the brain but lower in the pancreas and Harderian glands at both the 15-and 60-min time points. However, percent injected dose per gram values in the heart, kidney, liver, muscle, and preputial glands were approximately similar. Freeze-drying and reimaging of the sections indicated that a much higher percentage of the radioactivity was volatile in the 4-methylpyrazole-treated animals than in untreated animals, especially at the 60-min time point; this result is consistent with inhibition of [1-
14 C]ethanol metabolism by this compound.
Discussion
The main pathway for initial ethanol metabolism in animals is via alcohol dehydrogenase. This enzyme is most abundant in the liver, but lower levels are also found in other organs (Kovar et al., 1983) . After oxidization of ethanol to acetaldehyde, the acetaldehyde is oxidized further to acetate by aldehyde dehydrogenase. The acetate may then enter the tricarboxylate cycle (Isselbacher and Greenberger, 1964a,b) or the long-chain fatty acid synthesis pathway (Hakkinen and Kulonen, 1959; Smith and Newman, 1960) . Carbon atoms from labeled acetate are ultimately oxidized to carbon dioxide by the tricarboxylate cycle but are also incorporated into other compounds, including the amino acids glutamate and aspartate, that are metabolically connected to cycle intermediates. Thus, depending on the time after [1-
14 C]ethanol administration and the physiological state of the animal, residual radioactivity from [1-14 C]ethanol will represent different combinations of ethanol, acetaldehyde, acetate, bicarbonate, intermediary metabolites, and more complex molecules.
In the mouse experiment in the present study, overall radioactivity (Marshall and Owens, 1955) , and the actual amount of ethanol delivered to the mice in the current study was relatively small (80 mg/kg). This small amount of ethanol may account for the relatively rapid conversion of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]ethanol to nonvolatile metabolite observed in the study.
A more detailed picture of the biodistribution of radiolabeled ethanol and its metabolites among various organs was obtained in the present study using whole-body autoradiography in rats. This revealed high concentrations of radioactive material at both the 15-and 60-min time points in glandular structures such as the Harderian, salivary, and preputial glands as well as in the liver and pancreas. In the case of the liver, the high levels of radioactivity in this organ are consistent with its central role in ethanol metabolism and in biosynthesis of proteins and complex lipids.
Examination of the loss in radioactivity from freeze-drying the sections indicated that at the 15-min time point approximately half of the radioactivity in the sections was volatile, assumed to mostly represent radioactivity due to unmetabolized [1-
14 C]ethanol. However, at the 60-min time point only a minor loss in radioactivity by drying the sections was observed. The latter result indicates that most of the ethanol had been converted to nonvolatile metabolites by this time point. The time course for conversion of ethanol to nonvolatile metabolites was slower in the rat autoradiographic studies than in the mouse studies, consistent with the larger body size of this species. In comparison, the blood half-life of ethanol after a pharmacological i.v. dose (250 mg/kg) in rats is approximately 30 min (Caballeria et al., 1989) . This is slower than the rate of loss of volatile material observed in the present rat autoradiographic study, although because lower ethanol doses were used in the present study (ϳ90 mg/kg) a faster rate of metabolism is to be expected.
Especially notable in the current study was the high concentration of radioactivity in the pancreas, which was significantly above that in most of the other major organs, including the liver. High levels of radioactivity in the pancreas were also apparent in whole-body autoradiographic images of a monkey fetus taken after [
14 C]ethanol administration to the mother in the study by Ho et al. (1972) . These observations are intriguing in view of the well documented occurrence 
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at ASPET Journals on June 24, 2017 dmd.aspetjournals.org of pancreatitis in chronic alcoholism (Singh and Simsek, 1990; Apte et al., 1998 Apte et al., , 2006 . It is thus tempting to speculate that the susceptibility of this organ to damage may be related to a high propensity to accumulate ethanol and/or reactive metabolites from ethanol metabolism. Pancreatic acinar cells are capable of metabolizing ethanol via both the oxidative and nonoxidative pathways (Haber et al., , 2004 Gukovskaya et al., 2002) . The latter occurs by esterification of ethanol with fatty acids, resulting in the formation of fatty acid ethyl esters (Wilson and Apte, 2003) . The products of both oxidative metabolism of ethanol (acetaldehyde and reactive oxygen species) and nonoxidative metabolism of ethanol (fatty acid ethyl esters) have deleterious effects on pancreatic tissue (Nordback et al., 1991; Wilson and Apte, 2003) . In the present study the accumulation of radioactivity from [ 14 C]ethanol in the pancreas was diminished in the rats given prior treatment with 4-methylpyrazole. This finding suggests that at least part of the accumulation and trapping of 14 C in this organ involves metabolism of [ 14 C]ethanol by alcohol dehydrogenase rather than via nonoxidative pathways. The metabolism and trapping of radiolabeled ethanol may occur either directly by the organ itself or by the accumulation and trapping of circulating 14 C metabolites (e.g., acetate) . Further studies with radiolabeled ethanol and ethanol metabolites on isolated pancreatic tissue would be needed to distinguish between these possibilities. In comparing the relative importance of the oxidative and nonoxidative pathways in the pancreas, it has been observed that in isolated rat pancreatic acini incubated in alcohol, the rate of oxidative metabolism is 20-fold higher than the rate of nonoxidative metabolism (Gukovskaya et al., 2002; Haber et al., 2004) . This observation would be consistent with the accumulation of 14 C in the pancreas observed in the present study resulting primarily from oxidative pathways of metabolism. However, it should also be noted that fatty acid ethyl ester formation is much enhanced in animals treated with 4-methylpyrazole (Manautou and Carlson, 1991) , suggesting that these compounds may nonetheless have made up a significant component of the residual nonvolatile metabolites in the case of the 4-methylpyrazole-treated animals.
The preputial gland was observed to exhibit a high uptake of radiolabel in the current study, with most of the radioactivity being volatile, even at the 60-min time point. The preputial gland of rodents appears to be specialized for synthesis of pheromones (Novotny, 2003) , but the human preputial gland has been implicated as a target of maternal drinking (Amankwah et al., 1982) . Because ethanol is not expected to be a substrate for active transport processes, ethanol accumulation in this structure could be explained by passive transfer of ethanol from blood during the initial distribution phase to a tissue compartment from which it is denied ready access back to the circulation. Because of the involvement of the preputial gland in pheromone synthesis, it is possible that the trapping mechanism may involve incorporation of the radiolabel into a volatile pheromone compound. The accumulation of [ 14 C]ethanol in the preputial gland was little affected by prior dosing of the animal with 4-methylpyrazole, which may suggest that any such metabolic trapping mechanism for ethanol in this gland occurs mostly via a nonoxidative mechanism, such as esterification, for example, rather than via products from alcohol dehydrogenase activity.
Particularly high levels of radiolabel were observed in the present autoradiographic study in the Harderian gland. The Harderian glands are exocrine glands that are present in rodents, birds, amphibians, and reptiles but are vestigial in primates (Buzzell, 1996) . Their main secretory product is lipid (Buzzell, 1996) . The marked accumulation of radiolabel from ethanol in these organs is thus intriguing. The trapping mechanism appears to involve alcohol dehydrogenase activity, at least in part, because the accumulation of radiolabel in these organs was significantly lowered in the rats given prior treatment with 4-methylpyrazole.
The level of radioactivity in the brain after [
14 C]ethanol administration to the rats was low and below that in the blood, which suggests an exclusion of charged or polar circulating radiolabeled metabolites of ethanol by the blood-brain barrier. This hypothesis is supported by the fact that a higher level of radiolabel was observed in the brain when the rats were pretreated with 4-methylpyrazole. In these animals, plasma levels of unmetabolized [ (Cruz et al., 2005; Volkow et al., 2006) . Although radioactivity in the blood and most organs dropped between the 15-and 60-min sacrifice time points in the rats, radioactivity levels increased substantially in the lumen of the small intestine, probably reflecting partial elimination of ethanol or its metabolites via the hepatobiliary system.
In conclusion, our quantitative whole-body imaging study of i.v. [1-
14 C]ethanol using phosphor screen autoradiography supplements older nonquantitative studies using photographic film. The highest concentrations of 14 C were imaged in Harderian and preputial glands, intestinal contents, and pancreas. This study is the first autoradiographic study to provide images of the whole-body biodistribution of radiolabeled ethanol in a quantitative manner and significantly extends the results of earlier and less detailed nonquantitative studies. The study also provides initial animal data to support future positron emission tomographic studies to examine the biodistribution and pharmacokinetics 11 C-radiolabeled ethanol in clinical studies. 
